Patent US5013732A successfully refreshed from Google Patents.
US5013732A
Expired / Lapsed
US
⏱️ 0.0 years remaining
3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indoles
Assignee: Sanofi Aventis France
•
Filing: 1990-07-30
•
Granted: 1991-05-07
•
Expires: 2010-07-30
Abstract
Abstract 3-Arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, useful as analgesic, anti-rheumatic and anti-inflammatory agents, are prepared by reacting a 3-arylcarbonyl- or 3-cycloalkylcarbonylindole with an aminoalkyl halide in the presence of an acid-acceptor; by reacting a 1-aminoalkyl-1H-indole with an arylcarboxylic acid halide or a cycloalkanecarboxylic acid halide in the presence of a Lewis acid; or by reacting a 3-arylcarbonyl- or 3-cycloalkanecarbonyl-1-tosyloxyalkyl- or haloalkyl-1H-indole with an amine.
Inventors
- 👤 Malcolm R. Bell
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 16:49
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/12; C07D209/00; C07D209/02; C07D209/04; C07D209/08; C07D209/10; C07D209/12; C07D209/14; C07D209/30; C07D233/00; C07D233/54; C07D233/56; C07D249/00; C07D249/02; C07D249/08; C07D401/00; C07D401/02; C07D401/06; C07D401/10; C07D403/00; C07D403/02; C07D403/06; C07D403/10; C07D405/00; C07D405/02; C07D405/06; C07D409/00; C07D409/02; C07D409/06; C07D413/00; C07D413/02; C07D413/06
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
208 words
A compound having the formula: ##STR18## wherein: R 2 is hydrogen, lower-alkyl, chloro, phenyl or benzoyl (or phenyl or benzoyl substituted by from one to two substituents selected from halo, lower-alkyl, lower-alkoxy, hydroxy, amino, lower-alkylmercapto, lower-alkylsulfinyl or lower-alkylsulfonyl); R 3 is cyclohexyl, lower-alkoxycyclohexyl, phenyl (or phyenyl substituted by from one to two substituents selected from halo, lower-alkoxy, hydroxy, benzyloxy, lower-alkyl, nitro, amino, lower-alkylamino, di-lower-alkylamino, lower-alkoxy-lower-alkylamino, lower-alkanoylamino, benzoylamino, trifluroracetylamino, lower-alkyl-sulfonylamino, carbamylamo, lower-alkylmercapto, lower-alkylsulfinyl, lower-alkylsulfonyl, cyano, formyl and oximinomethylene), methylenedioxyphenyl, 3- or 4-hydroxy-1-piperidinylphenyl, 1-piperazinylphenyl, (1H-imidazol-1-yl)phenyl, (1-pyrrolyl)phenyl, aminomethylphenyl, guanidinylmethylphenyl, N-cyanoguanidinylmethylphenyl, styryl, lower-alkyl-substituted-styryl, fluorosubstituted-styryl, 2- or 4-biphenyl, 1- or 2-naphthyl (or1- or 2-naphthyl substituted by from one to two substituents selected from lower-alkyl, lower alkoxy, hydroxy, bromo, chloro, fluoro, lower-alkoxycarbonyl, carbamyl, cyano, lower-alkyl-mercapto, lower-alkylsulfinyl, lower-alkylsulfonyl and trifluoromethyl), thienyl, furyl, benzofuryl, benzothienyl, quinolyl, or (N-lower-alkyl)pyrrolyl; R 4 is hydrogen or from one to two substituents selected from lower-alkyl, hydroxy, lower-alkoxy and halo in the 4-, 5-, 6- or 7-positions; C=Z is C=O or C=NOH; and N=B is azido, amino, N-lower-alkylamino, N,N-dilower-alkylamino, N-(hydroxy-lower-alkyl)amino, N,N-di-(hydroxy-lower-alkyl)amino, N-lower-alkyl-N-(hydroxy-lower-alkyl)amino, N-(lower-alkoxy-lower-alkyl)amino, N-(halo-n-propyl)amino, 4-morpholinyl, 2-lower-alkyl-4-morpholinyl, 2,6-di-lower-alkyl-4-morpholinyl, 4-thiomorpholinyl, 4-thiomorpholinyl-S-oxide, 4-thiomorpholinyl-S,S-dioxide, 1-piperidinyl, 3-or 4-hydroxy-1-piperidinyl, 3- or 4-lower-alkanoyloxy-1-piperidinyl, 3- or 4-amino-1-piperidinyl, 3- or 4-(N-lower-alkanoylamino)-1-piperidinyl, 2-cyclohexylmethyl-1-piperidinyl, 1pyrrolidinyl, 3-hydroxy-1-pyrrolidinyl, 1-azetidinyl, 1-piperazinyl, 4-lower-alkyl-1piperazinyl, 4-lower-alkanoyl-1-piperazinyl, 4-carbo-lower-alkoxy-1-piperazinyl, hexahydro-4H-1,4-diazepin-4-yl or the N=BN-oxides thereof; or an acid addition salt thereof.
Claim 2
Dependent Claim
208 words
A compound having the formula: ##STR18## wherein: R 2 is hydrogen, lower-alkyl, chloro, phenyl or benzoyl (or phenyl or benzoyl substituted by from one to two substituents selected from halo, lower-alkyl, lower-alkoxy, hydroxy, amino, lower-alkylmercapto, lower-alkylsulfinyl or lower-alkylsulfonyl); R 3 is cyclohexyl, lower-alkoxycyclohexyl, phenyl (or phyenyl substituted by from one to two substituents selected from halo, lower-alkoxy, hydroxy, benzyloxy, lower-alkyl, nitro, amino, lower-alkylamino, di-lower-alkylamino, lower-alkoxy-lower-alkylamino, lower-alkanoylamino, benzoylamino, trifluroracetylamino, lower-alkyl-sulfonylamino, carbamylamo, lower-alkylmercapto, lower-alkylsulfinyl, lower-alkylsulfonyl, cyano, formyl and oximinomethylene), methylenedioxyphenyl, 3- or 4-hydroxy-1-piperidinylphenyl, 1-piperazinylphenyl, (1H-imidazol-1-yl)phenyl, (1-pyrrolyl)phenyl, aminomethylphenyl, guanidinylmethylphenyl, N-cyanoguanidinylmethylphenyl, styryl, lower-alkyl-substituted-styryl, fluorosubstituted-styryl, 2- or 4-biphenyl, 1- or 2-naphthyl (or1- or 2-naphthyl substituted by from one to two substituents selected from lower-alkyl, lower alkoxy, hydroxy, bromo, chloro, fluoro, lower-alkoxycarbonyl, carbamyl, cyano, lower-alkyl-mercapto, lower-alkylsulfinyl, lower-alkylsulfonyl and trifluoromethyl), thienyl, furyl, benzofuryl, benzothienyl, quinolyl, or (N-lower-alkyl)pyrrolyl; R 4 is hydrogen or from one to two substituents selected from lower-alkyl, hydroxy, lower-alkoxy and halo in the 4-, 5-, 6- or 7-positions; C=Z is C=O or C=NOH; and N=B is azido, amino, N-lower-alkylamino, N,N-dilower-alkylamino, N-(hydroxy-lower-alkyl)amino, N,N-di-(hydroxy-lower-alkyl)amino, N-lower-alkyl-N-(hydroxy-lower-alkyl)amino, N-(lower-alkoxy-lower-alkyl)amino, N-(halo-n-propyl)amino, 4-morpholinyl, 2-lower-alkyl-4-morpholinyl, 2,6-di-lower-alkyl-4-morpholinyl, 4-thiomorpholinyl, 4-thiomorpholinyl-S-oxide, 4-thiomorpholinyl-S,S-dioxide, 1-piperidinyl, 3-or 4-hydroxy-1-piperidinyl, 3- or 4-lower-alkanoyloxy-1-piperidinyl, 3- or 4-amino-1-piperidinyl, 3- or 4-(N-lower-alkanoylamino)-1-piperidinyl, 2-cyclohexylmethyl-1-piperidinyl, 1pyrrolidinyl, 3-hydroxy-1-pyrrolidinyl, 1-azetidinyl, 1-piperazinyl, 4-lower-alkyl-1piperazinyl, 4-lower-alkanoyl-1-piperazinyl, 4-carbo-lower-alkoxy-1-piperazinyl, hexahydro-4H-1,4-diazepin-4-yl or the N=BN-oxides thereof; or an acid addition salt thereof.
Claim 3
Dependent Claim
45 words
A compound according to claim 1 wherein: R 2 is lower-alkyl; R 3 is lower-alkoxy-substituted phenyl or 1-naphthyl; R 4 is hydrogen or halogen; C=Z is C=O; and N=B is azido, amino, N-lower-alkylamino, N,N-dilower-alkylamino, 4-morpholinyl, 1-piperidinyl, 1-pyrrolidinyl or 1 -azetidinyl; or an acid-addition salt thereof.
Claim 4
Dependent Claim
11 words
A compound according to claim 2 wherein R 4 is fluoro.
Claim 5
Dependent Claim
10 words
1-[2-Hydroxy-3-(4-morpholinyl)propyl]-5-fluoro-2-methyl-3-(4-methoxybenzoyl)-1H-indole or an acid-addition salt thereof according to claim 3,
Claim 6
Dependent Claim
42 words
An analgesic, anti-rheumatic or anti-inflammatory composition for the relief of pain or rheumatic or inflammatory conditions which comprises a pharmaceutically acceptable carrier and, as the active component thereof, an effective analgesic, anti-rheumatic or anti-inflammatory amount of a compound according to claim 1.
Claim 7
Dependent Claim
55 words
A method for the relief of pain or rheumatic or inflammatory conditions in a patient requiring such treatment which comprises administering orally or parenterally to such patient a medication in solid or liquid dosage form containing, as the active component thereof, an effective analgesic, anti-rheumatic or anti-inflammatory amount of a compound according to claim 1.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-05-06 | 1994-11-05 | 1995-05-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-05-06 | 1998-11-05 | 1999-05-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-05-06 | 2002-11-05 | 2003-05-07 | $7700.00 | Window Closed / Lapsed |